Administration of the GSK Respiratory Syncytial Virus Vaccine to Pregnant Persons in Error
Description
The GSK and Pfizer respiratory syncytial virus (RSV) vaccines are both indicated for adults aged 60 years and older, but only the Pfizer product is approved for use in pregnancy to prevent RSV-associated lower respiratory tract disease in infants
